home / stock / bcrx / bcrx articles

BCRX Articles, BioCryst Pharmaceuticals Inc. - From 02/12/24

Stock Information
Company Name: BioCryst Pharmaceuticals Inc.
Stock Symbol: BCRX
Market: NASDAQ
Website: biocryst.com
Menu
BCRX BCRX Quote BCRX Short BCRX News BCRX Articles BCRX Message Board
Get BCRX Alerts

News, Short Squeeze, Breakout and More Instantly...
BioCryst to Report Fourth Quarter 2023 Financial Results on February 26 | Benzinga

RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company ...
BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting | Benzinga

RESEARCH TRIANGLE PARK, N.C. , Feb. 05, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company...

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guida...

What's Going On With BioCryst Pharmaceuticals Stock? | Benzinga

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares are trading higher Monday. The company provided preliminary, unaudited net revenue figures for...
BioCryst Announces Preliminary Full Year 2023 ORLADEYO® (berotralstat) Net Revenue of $325 Million, Provides 2024 Guidance and Accelerated Path to Profitability | Benzinga

—ORLADEYO preliminary 2023 full year net revenue of $325 million (+29 percent y-o-y)— —ORLADEYO net revenue expected to be between $380-$400...

BioCryst to Present at 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company ...

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. AeroVironment posted ad...
BioCryst to Present at Upcoming Investor Conferences | Benzinga

RESEARCH TRIANGLE PARK, N.C., Nov. 21, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the company w...

BioCryst R&D Day Highlights New Diversified Pipeline of First-in-Class/Best-in-Class Therapies with Five Programs Expected in Clinical Development in Next 24 Months | Benzinga

Company builds on deep structure-based drug design capabilities to add protein therapeutics to pipeline: BCX17725 for Netherton syndrome — ent...

BioCryst to Host R&D Day on November 3 | Benzinga

RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company ...
Previous 10 Next 10